BAFFR-targeting CAR-T cells

· PeproMene Bio, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BAFFR-targeting CAR-T cells, covering 2025-11-20 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL [Phase 1]